Health
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2 – News-Medical.Net
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to…
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Tetanus toxoid (TT) is a chemically inactivated version of the tetanus toxin produced by the bacteria Clostridium tetani. This chemically inactivated antigen can be used as a protein carrier in vaccines to induce potent…
-
Noosa News18 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News22 hours agoBrisbane news live: Pedestrian hit by truck on Warrego Highway, road closed